Debunking the Top 4 Cannabis Oil Myths

February 7, 2020 09:00:09

The journey hasn’t been easy for hemp, and it might be a little rough before things get better. The crop had been outlawed for decades before the Farm Bill legalized it in December 2018. The legislation gave farmers leeway to grow the crop under state and tribal programs and within a year, hemp was worth millions in sales.

Most of the demand for hemp is due to cannabidiol (CBD). It is one of the over 100 cannabinoids produced by hemp, and it is said to have numerous medicinal properties. Once extracted, the oil can be used in a variety of ways, from tinctures and topicals to CBD-infused foods and beverages. However, hemp has had a PR problem for a while, what with its similarity to…


About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published:

Do you have a questions or are you interested in working with CNW? Ask Our Editor

Denver, Colorado
303.498.7722 Office

CBDWire is part of the InvestorBrandNetwork.